XLRN

Acceleron Pharma
XLRN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

8 hedge funds and large institutions have $11.7M invested in Acceleron Pharma in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.34M
2
+$2.22M
3
+$1.95M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.56M
5
ICAP
Independence Capital Asset Partners
Colorado
+$835K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.34M
2
$2.22M
3
$1.95M
4
$1.56M
5
$835K
6
$445K
7
$362K
8
$1K